Fp. Jansen et al., CHARACTERIZATION OF THE BINDING OF THE FIRST SELECTIVE RADIOLABELED HISTAMINE H-3 RECEPTOR ANTAGONIST, [I-125] IODOPHENPROPIT, TO RAT-BRAIN, British Journal of Pharmacology, 113(2), 1994, pp. 355-362
1 The binding of the first selective radiolabelled histamine H-3-recep
tor antagonist [I-125]-iodophenpropit to rat cerebral cortex membranes
was characterized. 2 [I-125]-iodophenpropit, radiolabelled to a high
specific activity of 1900 Ci mmol(-1), saturably bound to a single cla
ss of sites with a K-D of 0.57 +/- 0.16 nM (n = 4) and B-max of 268 +/
- 119 fmol mg(-1) protein. 3 Specific binding at a concentration below
1 nM represented 50 to 60% of total binding. 4 Binding of [I-125]-iod
ophenpropit to rat cerebral cortex membranes was readily displaced by
histamine H-3-agonists and antagonists. In contrast, the inhibitory po
tencies of selective histamine H-1- and H-2-receptor ligands were very
low. 5 [(125)]-iodophenpropit was biphasically displaced by the hista
mine H-3-receptor antagonists, burimamide and dimaprit, which may indi
cate the existence of histamine H-3-receptor subtypes. Other histamine
H-3-receptor antagonists showed a monophasic displacement. 6 Competit
ion binding curves of H-3-agonists were biphasic and showed a rightwar
d shift upon the addition of the nonhydrolysable GTP analogue, guanosi
ne 5'-o-(3-thio) triphosphate (GTP gamma S; 100 mu M) which implicates
the interaction of histamine H-3-receptors with G-proteins, The affin
ities of the H-3-receptor antagonists iodophenpropit, thioperamide and
burimamide were not altered by GTP gamma S. 7 Histamine competition b
inding curves were shifted to the right by different nucleotides (100
mu M) with a rank order of potency GTP gamma S>Gpp(NH)p, GTP.8 In vitr
o autoradiographic studies revealed a heterogeneous distribution of [I
-125]-iodophenpropit binding sites in rat brain, with highest densitie
s observed in specific cerebral cortical areas and layers, the caudate
-putamen complex, the olfactory tubercles, the hippocampal formation,
the amygdala complex, the hypothalamic area and the mammillary bodies.
9 It is concluded that the histamine H-3-receptor antagonist, [I-125]
-iodophenpropit, meets the criteria for a suitable radioligand for his
tamine H-3-receptor binding studies in rat brain.